Crown (ASX:CWN) share price lifts as controversial chair retires

Coonan was previously singled out by the Victorian Royal Commission as an unfit to oversee reforms of the company.

Bird's eye view of a pair of yellow shoes next to a goodbye sign written in chalk on the pavement

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Crown Resorts Ltd (ASX: CWN) share price is climbing in early trade this morning. That's after the company officially announced the retirement of chair Helen Coonan, effective today.

Coonan will be replaced by former Telstra Corporation Ltd (ASX: TLS) CEO Ziggy Switkowski. Jane Halton will act as interim chair until Switkowski is confirmed to his position.

At the time of writing, the Crown share price is trading at $9.44 – up 1.62%%. For context, the S&P/ASX 200 Index (ASX: XJO) is trading 0.05% lower.

Let's take a closer look at today's news.

'Ms Coonan…cannot be the critical face of change required at Crown'

It will be interesting to see how the Crown share price performs today as investors digest the latest news from the embattled casino operator.

Crown Resorts had already signalled to the Victorian Royal Commission looking into its gaming licence in the state that Coonan would leave by the end of this month. The pressure was on the former Howard government minister to step down from the board following a scathing submission by counsel assisting.

"Ms Coonan… cannot be the critical face of the change required at Crown if it is to remain the licensee," counsel assisting Adrian Finanzio told the Royal Commission at the time.

Finanzio had similarly harsh words for Crown Melbourne CEO Xavier Walsh. Walsh, too, resigned after those adverse comments were made against him. The Crown share price rose on this news.

In today's release, former chair Coonan said it was a "privilege" working at Crown, especially driving a "transformation of the culture, governance and compliance" of the company.

"My aim has been to stabilise and strengthen the business following the recommendations of the Bergin inquiry and set Crown on the reform path now being embedded across our world-class assets in Melbourne, Perth and Sydney," she said.

"I have always sought to act in the best interests of Crown and endeavoured to consider the impact on our shareholders, customers, and employees. I am confident the board's selection of Ziggy as chairman will reinforce the organisation-wide commitment to our reform program."

She did not address the allegations made against her at the Royal Commission. Crown, however, did previously respond to the comments at the Royal Commission. Counsel for Crown told the inquiry that no findings by counsel assisting "reflect[ed] adversely on her character, honesty, or integrity."

Dr Switkowski added he looked forward to joining the board, "growing value for shareholders, and continuing reforms at the company".

Crown share price snapshot

Over the past 12 months, the Crown share price has increased 0.43%. The ASX 200 is up 22.3% over the same period. The impacts of the Royal Commission saw Crown lose all the value it gained from multiple takeover approaches.

Crown has a market capitalisation of about $6.3 billion.

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Consumer Staples & Discretionary Shares

businessman handing $100 note to another in supermarket aisle representing woolworths share price
Consumer Staples & Discretionary Shares

How much could $5,000 invested in Coles shares be worth in a year?

Bell Potter sees big returns on the cards for owners of this stock.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Consumer Staples & Discretionary Shares

What are brokers saying about A2 Milk shares?

Is it time to snap up this stock or should you keep your infant formula powder dry?

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Consumer Staples & Discretionary Shares

Should you buy the dip on Woolworths shares?

Is this a good time to look at the supermarket business?

Read more »

Woman in dress sitting in chair looking depressed
Consumer Staples & Discretionary Shares

Cettire share price plunges 6% after major investor pulls the plug

A 'red flag' triggered this investment company to sell out completely.

Read more »

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.
Consumer Staples & Discretionary Shares

ASX experts: Lovisa share price has 28% upside

ASX brokers are still rating Lovisa as a compelling buy today.

Read more »

Two colleagues at work looking at a tablet and smiling at a rising share price.
Consumer Staples & Discretionary Shares

Buy this top ASX 200 stock for an 18% gain and 4% dividend yield

Bell Potter has resumed coverage on this stock and is feeling very positive.

Read more »

footwear asx share price on watch represented by look holding shoe and looking intently
Consumer Staples & Discretionary Shares

Does this ASX 300 retail stock really have a 7.6% dividend yield right now?

Is a 7.67% dividend yield too good to be true?

Read more »

A person eats a meat pie on the beach... what's more Australian than that?
Consumer Staples & Discretionary Shares

Which ASX shares could be next on the menu for Ozempic?

This broker believes the market for weight-loss drugs could grow tenfold. What could it consume on its way up?

Read more »